Literature DB >> 24610924

HDL in CKD: how good is the "good cholesterol?".

Ian H de Boer1, John D Brunzell2.   

Abstract

Entities:  

Keywords:  HDL; cardiovascular; chronic kidney disease

Mesh：

Substances：

Year:  2014        PMID： 24610924      PMCID： PMC4005321          DOI： 10.1681/ASN.2014010062

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  20 in total

1.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Authors:  Laxman Yetukuri; Sanni Söderlund; Artturi Koivuniemi; Tuulikki Seppänen-Laakso; Perttu S Niemelä; Marja Hyvönen; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Oresic
Journal:  J Lipid Res       Date:  2010-04-29       Impact factor: 5.922

3.  Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

4.  Lipoprotein heterogeneity in end-stage renal disease.

Authors:  J Joven; E Vilella; S Ahmad; M C Cheung; J D Brunzell
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

5.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Authors:  Amit V Khera; Marina Cuchel; Margarita de la Llera-Moya; Amrith Rodrigues; Megan F Burke; Kashif Jafri; Benjamin C French; Julie A Phillips; Megan L Mucksavage; Robert L Wilensky; Emile R Mohler; George H Rothblat; Daniel J Rader
Journal:  N Engl J Med       Date:  2011-01-13       Impact factor: 91.245

6.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; A Tchernof; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

Review 9.  Lipoprotein metabolism and renal failure.

Authors:  P O Attman; O Samuelsson; P Alaupovic
Journal:  Am J Kidney Dis       Date:  1993-06       Impact factor: 8.860

10.  Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis.

Authors:  Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237
View more
  10 in total

1.  High density lipoprotein cholesterol and risk of death.

Authors:  Ziyad Al-Aly
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Kidney function is associated with an altered protein composition of high-density lipoprotein.

Authors:  Katya B Rubinow; Clark M Henderson; Cassianne Robinson-Cohen; Jonathan Himmelfarb; Ian H de Boer; Tomas Vaisar; Bryan Kestenbaum; Andrew N Hoofnagle
Journal:  Kidney Int       Date:  2017-07-26       Impact factor: 10.612

Review 3.  Lipid lowering in renal disease.

Authors:  Alice Kennard; Richard Singer
Journal:  Aust Prescr       Date:  2017-08-01

4.  Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals.

Authors:  Michelle Averill; Katya B Rubinow; Kevin Cain; Jake Wimberger; Ilona Babenko; Jessica O Becker; Karen E Foster-Schubert; David E Cummings; Andrew N Hoofnagle; Tomas Vaisar
Journal:  J Clin Lipidol       Date:  2019-11-22       Impact factor: 4.766

5.  Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.

Authors:  Ching-Wei Tsai; Han-Chun Huang; Hsiu-Yin Chiang; Chih-Wei Chung; Shih-Ni Chang; Pei-Lun Chu; Chin-Chi Kuo
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

6.  High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.

Authors:  Benjamin Bowe; Yan Xie; Hong Xian; Sumitra Balasubramanian; Mohamed A Zayed; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 8.237

Review 7.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

8.  Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.

Authors:  Ahmed Bakillah; Fasika Tedla; Isabelle Ayoub; Devon John; Allen J Norin; M Mahmood Hussain; Clinton Brown
Journal:  Mediators Inflamm       Date:  2015-11-15       Impact factor: 4.711

9.  Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.

Authors:  Daniela Lucchesi; Simona Georgiana Popa; Veronica Sancho; Laura Giusti; Monia Garofolo; Giuseppe Daniele; Laura Pucci; Roberto Miccoli; Giuseppe Penno; Stefano Del Prato
Journal:  Cardiovasc Diabetol       Date:  2018-06-05       Impact factor: 9.951

10.  Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study.

Authors:  Jian Wang; Liwei Shi; Yunfeng Zou; Jiexia Tang; Jiansheng Cai; Yi Wei; Jian Qin; Zhiyong Zhang
Journal:  Aging (Albany NY)       Date:  2018-11-28       Impact factor: 5.682
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.